Laboratorio de Enfermedades Entéricas, Nutrición y Resistencia Antimicrobiana, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru.
Am J Trop Med Hyg. 2023 Mar 27;108(5):948-953. doi: 10.4269/ajtmh.22-0677. Print 2023 May 3.
Enterotoxigenic Escherichia coli (ETEC) ranks among the most relevant diarrheagenic pathogens. Efforts to design vaccines to fight ETEC have been focused on colonizing factors (CFs) and atypical virulence factors (AVF). An effective vaccine must account for differences in the regional prevalence of these CFs and AVFs to be truly effective in a given area. In the present study, the presence of 16 CFs and 9 AVFs, as well as the heat-stable (ST) variants (STh or STp), was established by polymerase chain reaction in 205 Peruvian ETEC isolates (120 from diarrhea cases and 85 from healthy controls). Ninety-nine (48.3%) isolates were heat-labile, 63 (30.7%) ST, and 43 (21.0%) presented both toxins. Of ST isolates, 59 (28.8%) possessed STh, 30 (14.6%) STp, five (2.4%) both STh and STp, and 12 (5.8%) were not amplified for any variant tested. The presence of CFs was associated with diarrhea (P < 0.0001). The presence of eatA as well as concomitant presence of CSI, CS3, and CS21 and of C5 and C6 was statistically related to diarrhea cases. The present results suggests that, if effective, a vaccine considering CS6, CS20, and CS21, together with EtpA, would provide protection against 64.4% of the isolates analyzed, whereas the addition of CS12 and EAST1 would lead to 83.9% coverage. Large studies are needed to establish both the ideal candidates to be considered to develop a vaccine effective in the area, and continuous surveillance is needed to detect displacement of circulating isolates that may compromise future vaccines.
肠产毒性大肠杆菌(ETEC)是最相关的腹泻病原体之一。设计疫苗以对抗 ETEC 的努力一直集中在定植因子(CFs)和非典型毒力因子(AVF)上。有效的疫苗必须考虑到这些 CF 和 AVF 在特定区域的流行差异,才能在该区域真正有效。在本研究中,通过聚合酶链反应在 205 株秘鲁 ETEC 分离株(120 株来自腹泻病例,85 株来自健康对照)中确定了 16 种 CF 和 9 种 AVF,以及耐热(ST)变体(STh 或 STp)。99 株(48.3%)分离株不耐热,63 株(30.7%)为 ST,43 株(21.0%)同时存在两种毒素。在 ST 分离株中,59 株(28.8%)具有 STh,30 株(14.6%)具有 STp,5 株(2.4%)同时具有 STh 和 STp,12 株(5.8%)未扩增任何变体。CF 的存在与腹泻有关(P < 0.0001)。eatA 的存在以及 CSI、CS3 和 CS21 的同时存在以及 C5 和 C6 的存在与腹泻病例呈统计学相关。本研究结果表明,如果有效,考虑到 CS6、CS20 和 CS21 以及 EtpA 的疫苗将为分析的 64.4%的分离株提供保护,而添加 CS12 和 EAST1 将导致 83.9%的覆盖率。需要进行大型研究以确定在该地区开发有效疫苗的理想候选物,并需要进行持续监测以检测循环分离株的替代情况,这可能会影响未来的疫苗。